Navigation Links
IBF/LifeScience Alley MedTech Investing Conference Adds Ashley Boam, Acting Deputy Director for Science and Review Policy, Office of Device Evaluation, Center for Devices and Radiological Health, FDA
Date:3/18/2008

Boam to address venture capitalists and venture-backed companies on the

present and future FDA regulation of medical devices

ST. LOUIS PARK, Minn., and Massapequa, N.Y., March 18 /PRNewswire/ -- Conference organizer International Business Forum (IBF) and LifeScience Alley, a Minneapolis trade association of medical device and other biotechnology firms, today announced that Ashley Boam, Acting Deputy Director for Science and Review Policy, Office of Device Evaluation at the Center for Devices and Radiological Health at FDA, will join the lineup of speakers at the 7th Annual MedTech Investing Conference (http://www.medtechconference.com) taking place at the Radisson Plaza Hotel in Minneapolis, Minnesota.

Boam will be interviewed by legal/regulatory firm DuVal & Associates President, Mark DuVal on the future of FDA's regulation of medical devices, clinical trials and approval requirements. They will discuss how FDA's changing requirements can impact the timeline to approval for medical devices and how that could impact the amount of investments in devices going forward.

This Fireside Chat is scheduled for 11:00 am on Thursday, May 14th, the second day of the conference. It will be the first time Ms. Boam presents at the MedTech Investing Conference which happens to be the premier event for medical device investors and entrepreneurs from around the nation.

To learn more about the event and to register, visit the newly launched website http://www.medtechconference.com.

About LifeScience Alley(TM)

LifeScience Alley(TM) is the largest trade association serving the life sciences in the Upper Midwest. It represents more than 570 member companies, organizations and institutions of all sizes that devote their efforts to the research, development and commercialization of the life sciences. LifeScience Alley acts as the industry's central resource for fostering innovation, offering education and creating consensus. It offers members unique opportunities to network and collaborate and provides them with a strong, unified voice at the state and federal level. Members hail from all life science industry sectors, including medical device, pharmaceutical, biopharmaceutical, health care providers and insurers, agricultural and industrial biotechnology, and renewable energy.

For more information, visit: http://www.lifesciencealley.org or call 952-542-3077.

About IBF

International Business Forum presents financial and business conferences on venture capital, corporate finance, mergers & acquisitions, corporate strategic investing, funding technology innovation, and commercialization of intellectual property. IBF conferences provide attendees with leading-edge information and new contacts to achieve business objectives. Visit http://www.ibfconferences.com for more details and complete information on upcoming events.


'/>"/>
SOURCE International Business Forum
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
2. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
3. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
4. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
5. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
6. IBF Conferences Inc., (International Business Forum) and BioEnterprise Present the 2nd Annual Global Healthcare Investing Conference
7. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
8. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
9. Avicena Group to Present at Noble Financial Conference
10. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
11. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... (PRWEB) , ... June 21, 2017 , ... ... attracting and hiring top executive talent in the life sciences industry, today announces ... Manufacturing company. The partnership takes full advantage of Beaker’s expertise in executive ...
(Date:6/22/2017)... ... June 21, 2017 , ... Building on the success of the inaugural RAADfest ... the very latest developments in radical life extension. RAADfest combines cutting edge science presented ... empowerment of personal development, making it the largest most comprehensive and inclusive super longevity ...
(Date:6/22/2017)... ... June 22, 2017 , ... Ovation Fertility supports the American ... bringing new hope for prospective parents who are challenged with costs of treatment. ... World Health Organization’s designation in hopes of changing the way health insurers, governments ...
(Date:6/22/2017)... Prussia, PA (PRWEB) , ... June 22, 2017 ... ... knowledge and superior results to clients throughout the biopharma and life sciences industries, ... changes the industry is seeing. Tunnell’s Kip Wolf will be speaking on “The ...
Breaking Biology Technology:
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
Breaking Biology News(10 mins):